26 studies found for:    " July 14, 2010":" August 13, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" July 14, 2010":" August 13, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Impact of Nutrition Intervention on HIV/AIDS Infected Patients
Conditions: Human Immunodeficiency Virus (HIV);   Acquired Immune Deficiency Syndrome (AIDS)
Interventions: Dietary Supplement: Theragran-M; Ensure Plus;   Dietary Supplement: Theragran-M
2 Withdrawn A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
Conditions: HIV Infections;   Acquired Immune Deficiency Syndrome
Interventions: Drug: Raltegravir plus Truvada;   Drug: Atripla
3 Unknown  Reducing HIV in Adolescents
Condition: HIV Infections
Interventions: Behavioral: Cash incentives;   Behavioral: Life skills curriculum
4 Active, not recruiting Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial
Condition: HIV-1
Intervention: Genetic: OZ1 transduced cells
5 Unknown  Chronic HIV Infection and Aging in NeuroAIDS (CHAIN)
Conditions: HIV;   Aging
Intervention: Other: Observational
6 Unknown  Pilot Study of Raltegravir Lipodystrophy IISP
Condition: HIV Infection
Intervention: Drug: Raltegravir
7 Completed Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+
Condition: HIV Seropositivity
Interventions: Other: ARV's + Placebo;   Drug: Naltrexone;   Drug: Naltrexone + ARV's
8 Active, not recruiting A Safety and Immunogenicity Study of a Plasmid DNA Prime and MVA Boost Vaccine in HIV-1 (Human Immunodeficiency Virus-1) Infected Adults on ART
Condition: HIV-1 Infection
Intervention: Biological: JS7 plasmid DNA and MVA62B vaccine
9 Completed Study of Human Papillomavirus Related Genital Pathology Among HIV Positive Women
Condition: HIV Infections
Intervention: Procedure: surgical management of high grade lesions
10 Unknown  Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?
Conditions: HIV Infections;   Herpes Simplex
Interventions: Drug: Valacyclovir;   Drug: Placebo
11 Completed Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM)
Condition: HIV Infections
Interventions: Biological: blood test: rapid finger-stick blood specimen test;   Biological: blood test: conventional test
12 Completed Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor
Condition: HIV Infection
Interventions: Drug: Lopinavir and ritonavir;   Drug: Triple therapy with ritonavir
13 Completed Computer-Assisted Tailored Cue-card Health [CATCH] Study
Conditions: Human Immunodeficiency Virus;   STDs;   Hepatitis, Viral, Human
Intervention: Behavioral: Tailored Cue Cards
14 Recruiting Tenofovir, Emtricitabine, Efavirenz and Atazanavir Pharmacokinetics in the Aging HIV-Infected Population
Condition: Human Immunodeficiency Virus
Interventions: Drug: tenofovir/emtricitabine/efavirenz (TDF/FTC/EFV);   Drug: tenofovir/emtricitabine (TDF/FTC);   Drug: Atazanavir (ATV);   Drug: Ritonavir;   Procedure: Phlebotomy
15 Terminated Intrauterine Insemination In HIV-Discordant Couples
Conditions: HIV-1;   Fertility;   Infertility
Intervention: Other: Sperm Washing with Intrauterine Insemination (IUI)
16 Unknown  HIV Indicator Diseases Survey Across Europe - UK Arm
Conditions: HIV;   AIDS;   Indicator Diseases/Indicator Conditions
Interventions: Other: HIV test (serological or salivary);   Other: Interview
17 Completed Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects
Condition: Herpes Zoster
Interventions: Biological: Herpes Zoster Vaccine 1437173A;   Biological: Placebo
18 Unknown  Impact of Raltegravir on HIV-1 cDNA Slope Following Antiretroviral Therapy (ART) Initiation
Condition: HIV-1
Intervention:
19 Completed A Phase II/III Trial of Lopinavir/Ritonavir Dosed According to the WHO Pediatric Weight Band Dosing Guidelines
Condition: HIV
Intervention: Drug: Lopinavir/ritonavir
20 Active, not recruiting Linkage and Retention: A Randomized Trial to Optimize HIV/TB Care in South Africa
Condition: HIV
Intervention: Behavioral: Health System Navigator

Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results
Indicates status has not been verified in more than two years